Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5545-52-8
2. N-cbz-l-aspartic Acid 4-tert-butyl Ester
3. (2s)-4-[(2-methylpropan-2-yl)oxy]-4-oxo-2-(phenylmethoxycarbonylamino)butanoic Acid
4. N-benzyloxycarbonyl-l-aspartic Acid 4-tert-butyl Ester
5. 4-tert-butyl Hydrogen N-((phenylmethoxy)carbonyl)-l-aspartate
6. Cbz-l-aspartic 4-tert-butyl Ester
7. Z-l-aspartic Acid 4-tert-butyl Ester
8. Cbz-l-aspartic Acid 4-tert-butyl Ester
9. Z-asp(otbu)-oh.h2o
10. Mfcd00042857
11. (s)-2-(((benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic Acid
12. Cbz-asp(obut)-oh
13. Z-asp(otbu)-oh.dcha
14. Einecs 226-912-0
15. Cbz-asp(o-t-bu)
16. Z-asp(o-tbu)-oh
17. Z-l-asp(otbu)-oh
18. Z-asp(otbu)-oh?2o
19. Schembl1143898
20. Dtxsid90204015
21. Zinc2391156
22. Akos015889943
23. Akos015924110
24. L-aspartic Acid, N-[(phenylmethoxy)carbonyl]-, 4-(1,1-dimethylethyl)ester
25. Cs-w011994
26. Hy-w011278
27. N-cbz-aspartic Acid 4-tert-butyl Ester
28. As-11713
29. Db-030162
30. Z-asp(otbu)-oh, >=98.0% (tlc)
31. M03044
32. 545z528
33. W-105562
34. N-(benzyloxycarbonyl)-3-(tert-butoxycarbonyl)-l-alanine
35. (s)-2-benzyloxycarbonylamino-succinic Acid 4-tert-butyl Ester
36. (s)-2-benzyloxycarbonylamino-succinic Acid-4-tert-butyl Ester
37. (s)-2-(benzyloxycarbonylamino)-4-tert-butoxy-4-oxobutanoic Acid
| Molecular Weight | 323.34 g/mol |
|---|---|
| Molecular Formula | C16H21NO6 |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 323.13688739 g/mol |
| Monoisotopic Mass | 323.13688739 g/mol |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 423 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
36
PharmaCompass offers a list of L-Asp(OtBu)NCA API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L-Asp(OtBu)NCA manufacturer or L-Asp(OtBu)NCA supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Asp(OtBu)NCA manufacturer or L-Asp(OtBu)NCA supplier.
PharmaCompass also assists you with knowing the L-Asp(OtBu)NCA API Price utilized in the formulation of products. L-Asp(OtBu)NCA API Price is not always fixed or binding as the L-Asp(OtBu)NCA Price is obtained through a variety of data sources. The L-Asp(OtBu)NCA Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EINECS 226-912-0 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EINECS 226-912-0, including repackagers and relabelers. The FDA regulates EINECS 226-912-0 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EINECS 226-912-0 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A EINECS 226-912-0 supplier is an individual or a company that provides EINECS 226-912-0 active pharmaceutical ingredient (API) or EINECS 226-912-0 finished formulations upon request. The EINECS 226-912-0 suppliers may include EINECS 226-912-0 API manufacturers, exporters, distributors and traders.
EINECS 226-912-0 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EINECS 226-912-0 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EINECS 226-912-0 GMP manufacturer or EINECS 226-912-0 GMP API supplier for your needs.
A EINECS 226-912-0 CoA (Certificate of Analysis) is a formal document that attests to EINECS 226-912-0's compliance with EINECS 226-912-0 specifications and serves as a tool for batch-level quality control.
EINECS 226-912-0 CoA mostly includes findings from lab analyses of a specific batch. For each EINECS 226-912-0 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EINECS 226-912-0 may be tested according to a variety of international standards, such as European Pharmacopoeia (EINECS 226-912-0 EP), EINECS 226-912-0 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EINECS 226-912-0 USP).
